Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CASSIOPEA SPA

Home Clinical Trial Sponsors and OrganizationsCASSIOPEA SPA

CASSIOPEA SPA

ACTIVE

VIA CRISTOFORO COLOMBO 1, Lainate, Milano, Italywww.cassiopea.comPublic11–50 employeesEstablished: 2013-01-01

Part of Cosmo Pharmaceuticals NV

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

12

5 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2013

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

6

50.0%

Phase 3

5

41.7%

Phase 2

1

8.3%

Trial Status Distribution

Active, not recruiting

5

41.7%

Completed

7

58.3%

Clinical Trials

Trials sponsored by this organization (12)

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)

Aug 2023762 participants

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss

Jun 2023703 participants

A Study to Investigate the Effects of Cortexolone 17α-propionate (and Its Metabolites) on Healthy Volunteers' Heart

Jun 201832 participants

An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris

Oct 201627 participants

An Open-Label, Long-Term Extension Study to Evaluate the Safety of Cortexolone 17a-Propionate (CB-03-01) Cream, 1% Applied Twice-Daily in Subjects with Acne Vulgaris - not available

Active, not recruiting

May 2016609 participants

Extension study to evaluate the Safety of CB-03-01 1% cream applied twice daily in subjects with Acne Vulgaris

Active, not recruiting

Apr 2016600 participants

An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

Mar 2016609 participants

Extension study to evaluate the Safety of CB-03-01 1% cream applied twicedailyin subjects with Acne Vulgaris

Active, not recruiting

Feb 2016609 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials12
Approvals
News

Back to Organizations